MedPath

H. Lee Moffitt Cancer Center and Research Institute, Inc.

H. Lee Moffitt Cancer Center and Research Institute, Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
First Posted Date
2004-04-02
Last Posted Date
2012-12-11
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00006032
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Comparison of Two Types of Biopsy in Patients With Breast Lesions

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Procedure: Low dose radioactive seed followed by surgery and mammogram
Procedure: Needle localized breast biopsy with specimen x-ray
First Posted Date
2004-04-02
Last Posted Date
2012-09-26
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
117
Registration Number
NCT00006031
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Phase 1
Completed
Conditions
Melanoma (Skin)
Interventions
Biological: Interferon alfa
Radiation: Radiation therapy
First Posted Date
2004-04-02
Last Posted Date
2012-09-25
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
24
Registration Number
NCT00005615
Locations
🇺🇸

Sylvester Cancer Center, University of Miami, Miami, Florida, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

CP-609,754 in Treating Patients With Advanced Solid Tumors

Phase 1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-03-16
Last Posted Date
2013-12-19
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00006085
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
First Posted Date
2004-02-12
Last Posted Date
2012-09-26
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
44
Registration Number
NCT00006047
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 1
Completed
Conditions
Plasma Cell Neoplasm
Multiple Myeloma
Interventions
Procedure: Autologous Stem Cell Rescue
First Posted Date
2004-02-02
Last Posted Date
2019-11-08
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
131
Registration Number
NCT00005792
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: Filgrastim
Procedure: Surgery
First Posted Date
2003-10-08
Last Posted Date
2012-09-25
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
45
Registration Number
NCT00005800
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2003-05-22
Last Posted Date
2010-09-09
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00006086
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide

Phase 1
Completed
Conditions
Leukemia
Interventions
First Posted Date
2003-05-07
Last Posted Date
2012-09-25
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
41
Registration Number
NCT00005793
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1
Completed
Conditions
Lung Cancer
Interventions
Biological: Autologous dendritic cell-adenovirus p53 vaccine
First Posted Date
2003-01-27
Last Posted Date
2014-05-09
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
56
Registration Number
NCT00049218
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath